Neovasc Inc  

(Public, TSE:NVCN)   Watch this stock  
Find more results for TSE:NVC
1.55
-0.05 (-3.13%)
Jul 21 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.54 - 1.59
52 week 0.58 - 4.44
Open 1.59
Vol / Avg. 0.00/18,274.00
Mkt cap 117.99M
P/E     -
Div/yield     -
EPS -1.57
Shares 78.90M
Beta 0.85
Inst. own     -

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin -529.58% -909.25%
Operating margin -440.32% -1590.43%
EBITD margin - -240.70%
Return on average assets -32.98% -108.09%
Return on average equity - -406.72%
Employees 147 -
CDP Score - -

Address

13562 Maycrest Way Suite 5138
RICHMOND, BC V6V 2J7
Canada
+1-604-2704344 (Phone)
+1-604-2704384 (Fax)

Website links

Description

Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.

Officers and directors

Paul L. Geyer Independent Chairman of the Board
Alexei J. Marko Chief Executive Officer, Director
Christopher Clark Chief Financial Officer, Corporate Secretary
Brian McPherson Chief Operating Officer
Vicki Lee Bebeau Vice President - Clinical Affairs
Randy Lane Vice President - Research & Development
Jane H. Hsiao Ph.D. Independent Director
Age: 69
Douglas Glen Janzen Independent Director
William O'Neill Independent Director
Age: 61
Steven D. Rubin Esq. J.D. Independent Director
Age: 56